linaclotide Capsules 290 mcg, 145 mcg

Dossier type
Dossier status
Ready to file
Country of origin
GMP approvals
Manufacturer #17925
The company’s goal is to exceed its accomplishments to improve the quality of living, as well as the hope and well-being of millions of people. The company’s dedication to quality has allowed it to achieve prestige and significant market share. The core focus of the company is the development, production, and marketing of pharmaceutical products designed to help healthcare providers improve healthcare delivery.

Manufacturer usually replies in 7 days

Linaclotide is a medication used to treat constipation and irritable bowel syndrome. Suppliers of linaclotide market it in the form of 0.072mg, 0.145mg and 0.29mg oral tablets. The developer and earliest manufacturer of linaclotide is Ironwood Pharmaceuticals, who first acquired marketing authorization for the drug in 2012. Currently, the two largest producers and suppliers of linaclotide are Allergan and Astellas, the latter of which markets the drug across Asian markets while Allergan covers all the other geographic markets where linaclotide is approved (e.g. the U.S. and Europe). With the patent for the drug still valid, generic versions of linaclotide have yet to become available on the pharmaceutical market from other manufacturing companies. One of the main alternatives to linaclotide is plecanatide, which is marketed under the trade name Trulance by manufacturer Synergy Pharmaceuticals.